Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival

Two first analyses of our clinical trial on TIL as adjuvant therapy for melanoma were published in 2002 and 2007. We present here an update of the clinical results after a 17-year median followup. In this trial, disease-free patients were randomly assigned to receive either TIL/IL-2 or IL-2. The rel...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Khammari, Amir, Knol, Anne-Chantal, Nguyen, Jean-Michel, Bossard, Céline, Denis, Marc-Guillaume, Pandolfino, Marie-Christine, Quéreux, Gaëlle, Bercegeay, Sylvain, Dréno, Brigitte
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2014
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3987883/
https://ncbi.nlm.nih.gov/pubmed/24741578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/186212
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky